Brind.
  1. FDA granted pre-market approval for Zephyr Valve.

Strong adoption of Zephyr valves drove revenue increase for Pulmonx.

1 report, 1 independent Updated Jul 31
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Strong adoption of Zephyr valves drove revenue increase for Pulmonx.

Who's involved

What this event is mainly about
ZephyrPulmonx (United States)

Keep exploring

Part of

FDA granted pre-market approval for Zephyr Valve. All 2 developments

The entities involved

Coverage

Newest first; wire copies grouped
  • GuruFocus.comPulmonx Corp (LUNG) Q2 2025 Earnings Call Highlights: Strong International Growth Amid US Challenges Release Date: July 30, 2025 For the complete transcript of the earnings call, please refer to the